Tag: Health care industry
-
U.S. opens tariff probe targeting Germany’s drug pricing policies
U.S. Trade Representative Jamieson Greer said Germany’s proposal to reduce spending on medicines was “a serious step backwards.”
-
Zealand Pharma stock suffered its two worst days on record. Here’s what’s next for the weight loss drugmaker
While the market’s enthusiasm for one of Zealand’s experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
-
UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.
-
Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.
-
Centene to offer buyouts to some employees as health insurer cuts costs
The health insurer Centene did not indicate to how many employees were offered buyouts or how much it is aiming to reduce its workforce.
-
Drugmakers race to find a place in the next wave of obesity drugs
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
-
USDA’s Rollins called screwworm a ‘little pest’ amid U.S. spread. Last year, she called it ‘terrifying’
The U.S. agriculture secretary is downplaying the threat posed by the spreading screwworm now compared with her more dire remarks last year.
-
What screwworm’s appearance in U.S. cattle could mean for beef prices this summer
The arrival of the invasive New World screwworm in Texas could hit consumers this summer with beef prices already an acute source of inflation.
-
The space race is coming for pharma: Why drug development is heading to lower Earth orbit
Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.
-
GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers’ race to bolster pipelines.
Latest News
Stay Connected
Categories
BBC News CNA CNBC CNN International Deutsche Welle (DW) Euronews France 24 General Global & European Specialized & Regional
Tags
amp Artificial intelligence Asia Breaking News: Markets Breaking News: Politics Breaking News: Technology Business business news china cup Donald J. Trump Donald Trump economy European Union fast football France germany Heatwave Investment strategy iran Iran war markets news People per politics return russia said Singapore spain Sport Stock markets technology trump ukraine United Kingdom United States US-Israel attack on Iran 2026 video War in Ukraine World world cup World Cup 2026
About the Author
AF themes
Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.
Search the Archives
Access over the years of investigative journalism and breaking reports
You May Have Missed
